All enrolled people who been given a minimum of 1 dose of zosuquidar or placebo in the course of induction had been monitored for your occurrence of adverse events (439 people, 219 on zosuquidar and 210 on placebo). The most common adverse situations ended up connected to the period of https://kareln887cmx0.wikievia.com/user